Gainers
- Heat Biologics Inc (NASDAQ: HTBX) shares rose 21.5 percent to $1.130 in pre-market trading after the company reported positive interim Phase 2 lung cancer results in patients treated with HS-110 in combination with a checkpoint inhibitor.
March 21, 2017 at 05:58PM
http://ift.tt/2nibAtO
from Lisa Levin
http://ift.tt/2nibAtO
No comments:
Post a Comment